- Con la presencia del ICE, habitantes de Minnesota crearon un sistema médico en las sombras. Un aprendizaje para otras ciudades
- As ICE Moved In, Minnesotans Set Up a Shadow Medical System. It’s a Lesson for Other Cities.
- Trump’s Cuts to Medicaid Threaten Services That Help Disabled People Live at Home
- Listen: What To Do When Health Insurance Slips Out of Reach
- Essentia Health shifts recreational therapists to tech roles; union protests changes
- Texas oral surgery practice opens 2 locations
- Intermountain cuts charting time 27% with AI assistant
- How 3 insurers are trying to tighten E/M billing oversight
- How 3 insurers are trying to tighten E/M billing oversight
- Texas orthodontics practices merge
- 73% of VA healthcare roles cut were recently filled: New York Times
- Network Health, backed by Cost Plus partnership, posts another year of record Medicare Advantage growth
- Network Health, backed by Cost Plus partnership, posts another year of record Medicare Advantage growth
- Children’s Health taps chief investment officer
- Appeals court could revive cardiologist’s anti-DEI retaliation lawsuit
- Mistrial declared in Virginia unlicensed dentistry case
- GI cancers to double by 2050: Report
- Private equity’s growing influence in healthcare — 6 recent deals
- Beth Israel Lahey Health CEO to step down next year
- 10 health systems named ‘exceptional workplaces’: Gallup
- Allegheny Health Network taps UH exec as chief nurse
- What It Takes to Deploy AI at Scale in Dentistry—and Why It Matters
- California system moves to delay layoffs
- California system moves to delay layoffs
- Why Prisma Health is betting big on outpatient expansion
- Anesthesia reimbursement decline over the last 5 years
- Federal resolution introduced to back fluoride use
- Salt Dental Partners expands in 3 states
- Cardiology and private equity in 2026: 5 notes
- UPMC gifted $1.25M to support care in North Central Pennsylvania
- NYC Health + Hospitals advances behavioral health strategy: 4 things to know
- Opening Remarks at Private Markets Roundtable
- 2 ASC consulting firms partner on united platform
- Strategic Radiology adds 14-physician practice
- Eli Lilly launches its direct-to-employer platform for obesity drugs
- 50 anesthesiology departments ranked by NIH funding
- Rhode Island lawmaker pushes for creation of new dental school: 6 notes
- Hospitals decry drugmakers' expanded claims reporting policies for 340B
- CMS releases toolkit for children’s behavioral health services
- Qventus Launches Care Gap and Coding Automation Suite to Improve Patient Care and Reimbursement Revenue
- $32M deal closes on Boston-area medical center
- Dental therapist bill fails in Florida Senate
- ECU Health opens 2 gastroenterology clinics following practice acquisition
- Straine Dental Management adds 6th Texas practice
- Newport Healthcare taps chief growth and experience officer
- Independent autism research committee forms amid concerns over federal panel
- 12 health systems seeking revenue cycle vice presidents
- CommonSpirit eyes ASC growth to diversify portfolio
- From -2.6% to 10.7%: How 12 academic systems’ margins compare
- Remarks at Financial Stability Oversight Council Artificial Intelligence Innovation Series Roundtable on Strategy and Governance Principles
- Collegium enrolls Paris Hilton in Jornay PM push encouraging ADHD community to 'Embrace Your Sparkle'
- Review of U.S. Measles Elimination Status Delayed Until November
- Your Furry Roommate May Be Affecting The Air You Breathe
- BioDuro enters Taiwan joint venture, adding commercial API plant to production network
- FDA answers Vanda's yearslong call for public hearing on unsuccessful jet lag approval bid
- MUSC Health acquires South Carolina's largest multispecialty practice for $111M
- Beth Israel Lahey Health back in the black in Q1
- About 81,000 Baby Monitors Recalled Over Possible Fire Risk
- Armed with funding and an acquisition, Procode AI launches AI-powered RCM for surgical billing
- Charities merge to form nation's 'most comprehensive' patient assistance nonprofit
- Two Days of Oatmeal May Lower Cholesterol, Study Finds
- Bayer looking at another year of 'resilience' before growth kicks in behind Nubeqa, Kerendia
- Colorectal Cancer Rates Shifting to Younger Groups as Rectal Cancer Rates Spike
- Brain Chemical Provides A 'Pep In Your Step,' Experiment Shows
- Lithium Might Slow Brain Decline Among Seniors, Pilot Study Shows
- Exercise Boosts Quality of Life During Breast Cancer Chemotherapy
- Early Sports Specialization Linked To Increased Injury Risk
- More Kids, Teens Injured In E-Bike Wrecks, Study Finds
- Novo lands another FDA untitled letter, this time for Apple-inspired Ozempic ad
- Moderna fronts $950M to settle yearslong COVID patent litigation with Genevant, Arbutus
- Lawmakers, Health Groups Resist Their States’ Rural Health Fund Plans
- Despite Their Successes, Some Mobile Crisis Response Teams Are in Crisis
- Healthcare’s mixed Q4, plus insights from the Lake Nona Impact Forum
- Danish agency NoA Health names new CEO to drive global expansion
- Sanofi strikes $1.5B global licensing deal for Sino Biopharm's first-in-class JAK/ROCK asset
- Bassett Healthcare Network appoints division chief of dental services
- Aetna fined $550K for mental health parity violations
- Why CommonSpirit is exiting Conifer
- California provider opens teen mental health center
- Inside Huntsman’s hybrid model boosting social worker capacity sixfold
- FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters
- FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters
- HCA Healthcare says all-time high inpatient occupancy, ACA exchange attrition won't spoil 2026 volume growth
- Maryland awards $1.6M for substance use disorder, peer recovery workforce expansion
- Pfizer CEO Albert Bourla on FDA official Vinay Prasad: 'We have a problem with the leadership of CBER'
- Papa rolls out new program for insurers called Papa Plus
- Ireland’s biopharma appeal holds up amid unsteady geopolitical backdrop, US investment blitz
- San Diego provider opens 32-bed residential mental health facility
- AI Therapist? It Falls Short, a New Study Warns
- Grow Therapy scores $150M to build out enterprise partnerships with docs, employers
- Rising Stars: Boehringer’s Chris Kraemer on the power of patient impact
- Nearly 20 States Scale Back HIV Medication Programs
- BBQ Sauce Recall Issued Nationwide Due To Incorrect Label
- FDA Recalls More Than 651,000 Jugs of Water Over Sanitation Concerns
- Listen to the Latest ‘KFF Health News Minute’
- Hasta los pacientes se sorprenden por los precios que sus aseguradoras están dispuestas a pagar, un costo que al final pagamos todos
- Patients with multiple chronic diseases are a looming threat to health systems' financials: Vizient
- Guardant picks Patrick Dempsey for colorectal cancer blood test awareness
- Breast Cancer Cases, Deaths Expected To Rise Worldwide
- Collagen Supplements Good For Skin, Arthritis, Evidence Review Concludes
- Illicit Adderall Use Places Stress On The Heart, Study Shows
- A-Fib Drug, Diltiazem, Could Interact With Blood Thinners, Increase Risk Of Dangerous Bleeding
- How to Get Ready For Daylight Saving Time
- Effective Sunscreen Protection Can Cost $40 A Year
- Longtime Cigna CEO David Cordani to retire, Brian Evanko tapped as successor
- Acadia, undaunted by recent EU rejection, seeks CHMP re-examination of Rett syndrome med Daybue
- FDA’s CRLs reveal critical errors in AstraZeneca’s Saphnelo data, efficacy doubts for GSK’s Exdensur
- Readers Lean On Congress To Solve Crises in Research and Rehab
- Even Patients Are Shocked by the Prices Their Insurers Will Pay — And It Costs All of Us
- Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug
- Novo plugs $500M into Ireland plant to produce Wegovy pill for markets outside US
- Esperion pays $75M-plus to acquire Corstasis and newly approved Enbumyst
- In 1 state, large hospitals dominate 340B's net savings
- HHS bans Claude AI tool as Trump seeks full government blacklisting of Anthropic
- Report: Most states investing in value-based care with Rural Health Transformation Program
- U.S. Tops 1,100 Measles Cases This Year as Outbreaks Grow
- FDA To Offer Cash Bonuses for Faster Drug Reviews
- 'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing
- GLP-1s support heart attack recovery in rodents by relaxing tight blood vessels
- Former Optum CEO Heather Cianfrocco to depart UnitedHealth Group
- New Drug, Acoziborole, Could Boost Efforts to Wipe Out Sleeping Sickness
- Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug
- Amid unfolding Middle East war, pharma giants keep close eye on employee safety, supply chains
- CMS set to suspend enrollment in Elevance Health's Medicare Advantage plans
- Providers urge Education Department to reconsider which jobs face stiffer student loan caps
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Urban Traffic Noise Disrupts Sleep, Affects Heart Health After One Night
- Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients
- Benzodiazepine Use Down In U.S., But OD Risk Remains, Study Says
- GLP-1 Drugs Might Ease Chronic Migraine, Study Says
- Blood Test Reveals Alcohol-Related Liver Disease
- Telemedicine Visits Cost Five Times Less Than In-Clinic Care
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
- Tennr takes aim at phone call bottlenecks as it builds out automation for patient referral process
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Electronics Pollution Pose Added Threat to Endangered Dolphins, Porpoises
- Flea And Tick Pills May Pose Environmental Risks, Study Finds
- Statement on the Adoption of Final Rules Under the Holding Foreign Insiders Accountable Act
- Statement on Final Rules for the Holding Foreign Insiders Accountable Act
- State Medicaid budgets to weather $664B reduction through 2034 due to OBBBA: RAND
- New Obamacare Rules Could Raise Deductibles to $31K For Families
- Study Suggests One Common Amino Acid May Affect How Long Men Live
- Walmart Great Value Cottage Cheese Recalled Over Pasteurization Issue
- Chris Bosh Says He’s 'Lucky To Be Alive' After Sudden Health Scare
- How the Brain Learns to Have Seizures During Sleep
- Blood Test Can Predict Short-Term Survival Among Seniors
- Why Turning 19 Spikes Medicaid Loss for Millions
- Crash Course Might Speed Brain Stimulation Treatment For Depression, Study Suggests
Many long COVID sufferers feel that their real problems were ignored while public health went ape over COVID counts, transmission rates, and enforcing masks and vaccines.
This New York Times report of serotonin-implicated research may finally help advance solutions for memory loss and other real problems of COVID.
Scientists Offer a New Explanation for Long Covid
Oct. 16, 2023
The News
A team of scientists is proposing a new explanation for some cases of long Covid, based on their findings that serotonin levels were lower in people with the complex condition.
In their study, published on Monday in the journal Cell, researchers at the University of Pennsylvania suggest that serotonin reduction is triggered by remnants of the virus lingering in the gut. Depleted serotonin could especially explain memory problems and some neurological and cognitive symptoms of long Covid, they say.
Why It Matters: New ways to diagnose and treat long Covid.
This is one of several new studies documenting distinct biological changes in the bodies of people with long Covid — offering important discoveries for a condition that takes many forms and often does not register on standard diagnostic tools like X-rays.
The research could point the way toward possible treatments, including medications that boost serotonin. And the authors said the biological pathway that their research outlines could unite many of the major theories of what causes long Covid: lingering remnants of the virus, inflammation, increased blood clotting and dysfunction of the autonomic nervous system.
“All these different hypotheses might be connected through the serotonin pathway,” said Christoph Thaiss, a lead author of the study and an assistant professor of microbiology at the Perelman School of Medicine at the University of Pennsylvania.
“Second of all, even if not everybody experiences difficulties in the serotonin pathway, at least a subset might respond to therapies that activate this pathway,” he said.
“This is an excellent study that identifies lower levels of circulating serotonin as a mechanism for long Covid,” said Akiko Iwasaki, an immunologist at Yale University. Her team and colleagues at the Icahn School of Medicine at Mount Sinai recently published a study that identified other biological changes linked to some cases of long Covid, including levels of the hormone cortisol. These studies could point to specific subtypes of long Covid or different biological indicators at different points in the condition.
The Back Story: A series of disruptions set off by bits of virus in the gut.
Researchers analyzed the blood of 58 patients who had been experiencing long Covid for between three months and 22 months since their infection. Those results were compared to blood analysis of 30 people with no post-Covid symptoms and 60 patients who were in the early, acute stage of coronavirus infection.
Maayan Levy, a lead author and assistant professor of microbiology at the Perelman School of Medicine, said levels of serotonin and other metabolites were altered right after a coronavirus infection, something that also happens immediately after other viral infections.
But in people with long Covid, serotonin was the only significant molecule that did not recover to pre-infection levels, she said.
The team analyzed stool samples from some of the long Covid patients and found that they contained remaining viral particles. Putting the findings in patients together with research on mice and miniature models of the human gut, where most serotonin is produced, the team identified a pathway that could underlie some cases of long Covid.
Here’s the idea: Viral remnants prompt the immune system to produce infection-fighting proteins called interferons. Interferons cause inflammation that reduces the body’s ability to absorb tryptophan, an amino acid that helps produce serotonin in the gut. Blood clots that can form after a coronavirus infection may impair the body’s ability to circulate serotonin.
Depleted serotonin disrupts the vagus nerve system, which transmits signals between the body and the brain, the researchers said. Serotonin plays a role in short-term memory, and the researchers proposed that depleted serotonin could lead to memory problems and other cognitive issues that many people with long Covid experience.
“They showed that one-two-three punch to the serotonin pathway then leads to vagal nerve dysfunction and memory impairment,” Dr. Iwasaki said.
There are caveats. The study was not large, so the findings need to be confirmed with other research. Participants in some other long Covid studies, in which some patients had milder symptoms, did not always show depleted serotonin, a result that Dr. Levy said might indicate that depletion happened only in people whose long Covid involves multiple serious symptoms.
What’s Next: A clinical trial of Prozac.
Scientists want to find biomarkers for long Covid — biological changes that can be measured to help diagnose the condition. Dr. Thaiss said the new study suggested three: the presence of viral remnants in stool, low serotonin and high levels of interferons.
Most experts believe that there will not be a single biomarker for the condition, but that several indicators will emerge and might vary, based on the type of symptoms and other factors.
There is tremendous need for effective ways to treat long Covid, and clinical trials of several treatments are underway. Dr. Levy and Dr. Thaiss said they would be starting a clinical trial to test fluoxetine, a selective serotonin reuptake inhibitor often marketed as Prozac, and possibly also tryptophan.
“If we supplement serotonin or prevent the degradation of serotonin, maybe we can restore some of the vagal signals and improve memory and cognition and so on,” Dr. Levy said.
https://www.nytimes.com/2023/10/16/health/long-covid-serotonin.html
Pam Belluck is a health and science writer whose honors include sharing a Pulitzer Prize and winning the Victor Cohn Prize for Excellence in Medical Science Reporting. She is the author of “Island Practice,” a book about an unusual doctor.
Ms. Belluck writes about a wide range of subjects, including the coronavirus pandemic, reproductive health, brain science, neurological disorders and mental health. Her work on Ebola with six colleagues won the 2015 Pulitzer Prize for international reporting and other awards. Her project about surgery for women traumatized by genital cutting won a Nellie Bly Award for Best Front Page Story and other honors. Ms. Belluck’s reporting on the devastating effects of Covid was honored with a New York Press Club Award and a Newswomen’s Club Front Page Award. She contributed, along with many colleagues, to the Times’s pandemic coverage, which earned the paper a 2021 Pulitzer for public service. Ms. Belluck, along with a photographer and translator, also won a New York Press Club award for reporting in Brazil on babies harmed by the Zika virus.Ms. Belluck has reported on Alzheimer’s from mountain villages in Colombia, a California prison and dementia centers in South Korea, and she has investigated the controversial Alzheimer’s drug Aduhelm. Her two-part series Mother’s Mind helped spur efforts to detect and treat maternal depression. She also covers lighter topics, including the discovery of the world’s oldest leather shoe (size 7, right foot, preserved for 5,500 years in sheep dung), and her piece on a lost cat navigating 200 miles home inspired a children’s book.
Her work has been chosen for The Best American Science Writing and The Best American Sports Writing. She won a Fulbright Scholarship and a Knight Journalism Fellowship and was selected to be a Ferris Professor of Journalism at Princeton University. She is frequently invited to speak about her work and has served on advisory boards related to science communication.
Her book, “Island Practice,” about a colorful and contrarian doctor whose patients have included Kennedys and a hermit in a vine igloo, is being considered for a TV series. In her spare time, Ms. Belluck is a jazz flutist.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















